1-4 of 4
Rajiv Bassi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A160: Combination of necitumumab with second- or third-generation EGFR tyrosine kinase inhibitors downregulates DNA repair mechanisms and induces durable tumor remissions in xenograft NSCLC models with EGFR mutations

Amelie Forest, Erik R. Rasmussen, Thompson N. Doman, Michael Amatulli, Rajiv Bassi, Gerald E. Hall, Jason R. Manro, Manisha Brahmachary, David Surguladze, Yung-mae M. Yao, Michael D. Kalos, Ruslan D. Novosiadly
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A160.
https://doi.org/10.1158/1535-7163.TARG-17-A160
Published: 01 January 2018
View article titled, Abstract A160: Combination of necitumumab with second- or third-generation EGFR tyrosine kinase inhibitors downregulates DNA repair mechanisms and induces durable tumor remissions in xenograft NSCLC models with EGFR mutations
Journal Articles

Inhibiting FGFR3 for enhancing the cytotoxic effects of cisplatin on bladder cancer cells and possible mechanisms

Dhanvanthri Deevi, Roberto DiRenzo, Huiling Li, Maria Malabunga, Marie Prewett, Rajiv Bassi, Weigang Wang, Larry Witte, James Tonra, Haijun Sun
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B48.
Published: 01 November 2007
View article titled, Inhibiting FGFR3 for enhancing the cytotoxic effects of cisplatin on bladder cancer cells and possible mechanisms
Journal Articles

Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers

Jacqueline F. Doody, Ying Wang, Sheetal N. Patel, Christopher Joynes, Sui Ping Lee, Jason Gerlak, Robin L. Rolser, Yanxia Li, Philipp Steiner, Rajiv Bassi, Dan J. Hicklin, Yaron R. Hadari
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2642–2651.
https://doi.org/10.1158/1535-7163.MCT-06-0506
Published: 15 October 2007
View article titled, Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers
Open the PDF for Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers in another window
Journal Articles

Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target

Nick Loizos, Yan Xu, Jim Huber, Meilin Liu, Dan Lu, Bridget Finnerty, Robin Rolser, Asra Malikzay, Anita Persaud, Erik Corcoran, Dhanvanthri S. Deevi, Paul Balderes, Rajiv Bassi, Xenia Jimenez, Christopher J. Joynes, Venkata R.M. Mangalampalli, Philipp Steiner, James R. Tonra, Yan Wu, Daniel S. Pereira, Zhenping Zhu, Dale L. Ludwig, Daniel J. Hicklin, Peter Bohlen, Larry Witte, Paul Kussie
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (3): 369–379.
https://doi.org/10.1158/1535-7163.MCT-04-0114
Published: 14 March 2005
View article titled, Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target
Open the PDF for Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target in another window